Related references
Note: Only part of the references are listed.2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu et al.
CELL METABOLISM (2020)
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Furong Liu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Bo Li et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits
Shitao Rao et al.
DIABETES CARE (2020)
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed
Aihong Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
COVID-19 and diabetes: Can DPP4 inhibition play a role?
Gianluca Iacobellis
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
Rimesh Pal et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
In response: Diabetes is a risk factor for the progression and prognosis of COVID-19
Charles D. Blanke
DIABETES-METABOLISM RESEARCH AND REVIEWS (2020)
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications
Daniel J. Drucker
ENDOCRINE REVIEWS (2020)
The ACE-2 in COVID-19: Foe or Friend?
Rinkoo Dalan et al.
HORMONE AND METABOLIC RESEARCH (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Prevalence and impact of diabetes among people infected with SARS-CoV-2
G. P. Fadini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
Angeliki M. Angelidi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
Nancy Chow et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
Neil Mehta et al.
JAMA CARDIOLOGY (2020)
COVID-19-associated vasculitis and vasculopathy
Richard C. Becker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Commentary: COVID-19 in patients with diabetes
Michael A. Hill et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Dexamethasone in the management of covid-19
Raymond M. Johnson et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia A systematic review, meta analysis, and meta-regression
Ian Huang et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study Rationale and Design
Derek C. Angus et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Ritesh Gupta et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study
Raju Reddy et al.
PLOS ONE (2019)
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection
Kirsten A. Kulcsar et al.
JCI INSIGHT (2019)
Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia
Hail M. Al-Abdely et al.
EMERGING INFECTIOUS DISEASES (2019)
Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study
Paz L. D. Ruiz et al.
DIABETOLOGIA (2018)
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies
Raminderjit Kaur et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes
Sridevi Gutta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
Heleia Roca-Ho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
Daiji Kawanami et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
Qi Wu et al.
SCIENTIFIC REPORTS (2017)
Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study
Maria Lonnrot et al.
DIABETOLOGIA (2017)
Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies
Sara J. Healy et al.
ENDOCRINE (2017)
The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes
Kevin D. Burns et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Viral infections in type 1 diabetes mellitus - why the β cells?
Anne Op de Beeck et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014
Basem M. Alraddadi et al.
EMERGING INFECTIOUS DISEASES (2016)
Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
Marina Romani-Perez et al.
ENDOCRINOLOGY (2015)
Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus
Yaoxian Liang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes
Lars Krogvold et al.
DIABETES (2015)
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study
Devjit Tripathy et al.
DIABETOLOGIA (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R. P. Dellinger et al.
INTENSIVE CARE MEDICINE (2013)
Diabetes Mellitus-Associated Vascular Impairment Novel Circulating Biomarkers and Therapeutic Approaches
Dimitris Tousoulis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Respiratory Infections in Early Life and the Development of Islet Autoimmunity in Children at Increased Type 1 Diabetes Risk Evidence From the BABYDIET Study
Andreas Beyerlein et al.
JAMA PEDIATRICS (2013)
Early Childhood Infections and the Risk of Islet Autoimmunity The Diabetes Autoimmunity Study in the Young (DAISY)
Janet K. Snell-Bergeon et al.
DIABETES CARE (2012)
Connecting Type 1 and Type 2 Diabetes through Innate Immunity
Justin I. Odegaard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Hygiene Hypothesis: An Explanation for the Increased Frequency of Insulin-Dependent Diabetes
Jean-Francois Bach et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes
Sami Oikarinen et al.
DIABETES (2011)
Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study
Trond Rasmussen et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies
Wing-Chi G. Yeung et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Jin-Kui Yang et al.
ACTA DIABETOLOGICA (2010)
Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes The Diabetes and Autoimmunity Study in the Young (DAISY)
Lars C. Stene et al.
DIABETES (2010)
The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes
S. J. Richardson et al.
DIABETOLOGIA (2009)
ACE and ACE2 activity in diabetic mice
Jan Wysocki et al.
DIABETES (2006)
Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS
J. K. Yang et al.
DIABETIC MEDICINE (2006)
Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)
JWM Chan et al.
THORAX (2003)
Share Paper
